The American Bottling Company v. BA Sports Nutrition, LLC

Superior Court of Delaware·Decided February 11, 2021·No. N19C-03-048 AML CCLD·Published

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

THE AMERICAN BOTTLING ) COMPANY, )

)

Plaintiff, ) C.A. No. N19C-03-048 AML CCLD )

v. )

)

BA SPORTS NUTRITION, LLC and ) THE COCA-COLA COMPANY, )

)

Defendants. )

Submitted: December 31, 2020 Decided: February 11, 2021

MEMORANDUM OPINION

Upon Plaintiff’s Motion to Compel Documents from Defendant Coca-Cola:

GRANTED IN PART

Upon Defendant Coca-Cola’s Cross-Motion to Compel Documents from Plaintiff and JAB Holding Co., LLC:

GRANTED IN PART

Garrett B. Moritz, Esquire, Elizabeth M. Taylor, Esquire of ROSS ARONSTAM & MORITZ LLP, Wilmington, Delaware, Robert C. Walters, Esquire, Russell H. Falconer, Esquire, and Megan Z. Hulce, Esquire, of GIBSON DUNN & CRUTCHER LLP, Dallas, Texas, Attorneys for Plaintiff The American Bottling Company.

Rolin P. Bissell, Esquire, James M. Yoch, Jr., Esquire, Michael A. Laukaitis, II, Esquire, and Kevin P. Rickert, Esquire of YOUNG CONAWAY STARGATT & TAYLOR, LLP, Wilmington, Delaware, Michael C. Holmes, Esquire, Craig E. Zieminski, Esquire, and Andrew E. Jackson, Esquire of VINSON & ELKINS LLP, Dallas, Texas, Attorneys for The Coca-Cola Company.

A. Thompson Bayliss, Esquire, Daniel J. McBride, Esquire, of ABRAMS & BAYLISS LLP, Wilmington, Delaware, David H. Bernstein, Esquire, Jyotin Hamid, Esquire, Jared I. Kagan, Esquire, and Matthew J. Petrozziello, Esquire, of DEBEVOISE & PLIMPTON LLP, New York, New York, Attorneys for Defendant BA Sports Nutrition, LLC.

LEGROW, J.

The plaintiff contends the Coca-Cola Company (“Coke”) tortiously interfered with the plaintiff’s distribution agreement with BA and Sports Nutrition, LLC (“Bodyarmor”) by requiring Bodyarmor to terminate the distribution agreement as a condition to Coke investing in Bodyarmor. Late in the discovery process, Coke produced an email previously redacted for privilege in which one of Coke’s executives recommended proceeding with the investment in Bodyarmor based on Coke’s counsel’s advice that Bodyarmor had a right to terminate the distribution agreement. Coke then permitted its witness to testify at deposition regarding conversations with counsel about the risk of liability associated with the distribution agreement’s termination. The plaintiff argues the email’s production and the executive’s testimony waived privilege as to Coke’s communications with counsel regarding the right to terminate the distribution agreement and the risk of liability associated with termination.

Coke does not seriously contest waiver but seeks to limit the fallout by arguing the Court must cabin the waiver narrowly to one particular topic and only to the advice communicated to Coke’s executives. Those limitations largely are inconsistent with the principles of fairness underlying the “at issue” exception to the attorney-client privilege. Coke need not, however, produce communications exchanged exclusively between its external counsel unless those communications reflect or recount counsel’s communications with Coke.

Coke also filed its own motion to compel, arguing the plaintiff waived privilege over its own analysis of the distribution agreement by (1) arguing that the contract’s termination was a “clear” breach, or (2) permitting the plaintiff’s witness to testify that he consulted counsel before ultimately concluding Bodyarmor had no termination right. This argument is unpersuasive because the plaintiff has not placed its privileged communications at issue and does not intend to rely at trial on counsel’s advice. The plaintiff has, however, narrowly waived privilege regarding the origins and revisions to one due diligence document.

BACKGROUND

In 2015, Bodyarmor entered into a distribution agreement (the “Distribution Agreement”) with the plaintiff, The American Bottling Company (“ABC”). The Distribution Agreement granted ABC the exclusive right to distribute Bodyarmor’s products in most of the United States for ten years.1 Three years later, however, Bodyarmor withdrew from that agreement and granted exclusive distribution rights to The Coca-Cola Company (“Coke”).

A. The Merger and the Coke Deal Bodyarmor’s decision to terminate arose in the early months of 2018, after ABC’s upstream parent company, Dr. Pepper Snapple Group, Inc. (“DPSG”) announced its intention to acquire Keurig Green Mountain, Inc. (“Keurig”) from its

1 Second Amended Complaint (“SAC”) ¶¶ 32-33.

parent JAB Holding Company, LLC (“JAB”) (the “Merger”) and rename itself Keurig Dr. Pepper Inc. (“KDP”).2 ABC alleges in its complaint that Bodyarmor and its Chairman and CEO, Mike Repole, initially supported the Merger. Following the Merger, however, Bodyarmor terminated the Distribution Agreement. Bodyarmor then granted Coke the exclusive right to distribute Bodyarmor’s products in exchange for Coke purchasing a fifteen percent stake in Bodyarmor for $300 million (the “Coke Deal”).3 The proceeds of Coke’s $300 million investment primarily funded a distribution to Repole and Bodyarmor’s management.4 When it terminated the Distribution Agreement, Bodyarmor took the position that ABC breached Section 10.2 of the Distribution Agreement by failing to request and obtain Bodyarmor’s approval of the Merger.5 Section 10.2 of the Distribution Agreement provided that ABC could not transfer the Distribution Agreement (or its duties under it) without Bodyarmor’s approval, which Bodyarmor could not withhold unreasonably.6 Bodyarmor contends the Merger effected a transfer of ABC’s rights and obligations under the Distribution Agreement. Bodyarmor therefore purportedly could terminate the agreement for “cause” and without paying the liquidated damages it would have been required to pay if it terminated the

2 Id. ¶¶ 47-48. 3 Id. ¶ 76. 4 Id. ¶ 105. 5 Id. ¶ 101. 6 Id. ¶ 42.

agreement without cause. According to ABC, the Merger did not amount to a transfer of the Distribution Agreement and, even if it did, Bodyarmor had no reasonable basis to withhold its approval.

In its tortious interference claim against Coke, ABC alleges (i) Coke conditioned its investment on Bodyarmor terminating its Distribution Agreement with ABC, and (ii) Coke did so even though it learned during due diligence that Bodyarmor’s termination would breach the Distribution Agreement.7 ABC alleges Coke offered Bodyarmor a premium valuation to induce it to breach the Distribution Agreement. In support of this allegation, ABC alleges Coke (i) refused to pay any termination fees Bodyarmor incurred for terminating the Distribution Agreement, and (ii) insisted that Bodyarmor indemnify Coke for any damages associated with that termination. ABC contends these indemnity provisions and Coke’s refusal to accept any liability associated with Bodyarmor’s termination of the Distribution Agreement were the key sticking points in negotiations surrounding the Coke Deal.

B. ABC brings its tortious interference claim ABC initially filed claims for breach of contract and promissory estoppel against Bodyarmor and a claim for tortious interference against Repole.8 After conducting discovery, including third-party discovery from Coke, ABC filed an

7 Id. ¶¶ 72-73, 131. 8 The Court recently dismissed the tortious interference claim against Repole for failure to state a claim. See Am. Bottling Co. v. Repole, 2020 WL 7787043 (Del. Super. Dec. 30, 2020).

amended complaint asserting a claim for tortious interference against Coke. The parties have exchanged extensive discovery and filed numerous discovery-related motions. Written discovery is now substantially complete, and the parties are in the midst of fact depositions.

Free access — add to your briefcase to read the full text and ask questions with AI

The American Bottling Company v. BA Sports Nutrition, LLC, (Del. Ct. App. 2021).

The American Bottling Company v. BA Sports Nutrition, LLC (The American Bottling Company v. BA Sports Nutrition, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Commodity Futures Trading Commission v. Weintraub
471 U.S. 343 (Supreme Court, 1985)
Zirn v. VLI Corp.
621 A.2d 773 (Supreme Court of Delaware, 1993)
Ramada Inns, Inc. v. Dow Jones & Co., Inc.
523 A.2d 968 (Superior Court of Delaware, 1986)
Citadel Holding Corp. v. Roven
603 A.2d 818 (Supreme Court of Delaware, 1992)